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Introduction
Stroke is one of  the major public health concerns and the 
second leading cause of  death globally1. Based on current 
trends, the burden of  stroke is expected to double by 20302. 
At a time when the incidence of  stroke is declining in high-
income countries, it is increasing in low- and middle-income 
countries, especially in Africa2. This increase is not surprising 
given that Africa is undergoing an epidemiological transition 
driven by socio-demographic and lifestyle changes3,4. The 
latter include increased consumption of  unhealthy diets, 
sedentary lifestyle, and excessive alcohol intake and smoking. 
Furthermore, the high prevalence of  HIV infection in sub-
Saharan Africa is also a driver of  stroke incidence, especially 
in young adults5,6. The burden of  stroke is compounded by 
the scarcity of  resources and the absence or inadequacy of  
treatment and prevention guidelines4,7.
Malawi is not exempt from the challenges experienced by 
other African countries in the optimal management of  
patients with stroke. Queen Elizabeth Central Hospital 
(QECH), the country’s largest tertiary health facility, does not 
have specialist neurology or stroke services and has limited 
capacity for radiological imaging8. Patients with stroke are 
managed on the general medical wards by internal medicine 
physicians. Through a recent collaboration with University 
College London (UCL), QECH is preparing to open a 
stroke unit (https://malawistrokeunit.org/) where patients 
with stroke will be managed by a specialist team9. Successful 
implementation of  this initiative requires identification 
of  key priority areas for intervention, which will facilitate 
the efficient deployment of  plans tailored to the patients’ 
needs. However, current stroke management practices and 
outcomes at the QECH are poorly documented. We aim to 
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The Queen Elizabeth Central Hospital (QECH) is preparing to set up the first stroke unit in Blantyre, Malawi. We conducted this audit 
to assess current stroke management practices and outcomes at QECH and identify priority areas for intervention.
Methods
From April to June 2018, we prospectively enrolled patients with acute stroke and collected data on clinical presentation, cardiovascular 
risk factors, investigations and interventions, in-hospital outcomes, and follow-up plans after discharge. The American Heart 
Association/American Stroke Association (AHA/ASA) guidelines were used as the standard of  care for comparison.
Results
Fifty patients with acute stroke were enrolled (46% women, 54% men). The mean age was 63.1 years (95% CI: 59.7–66.6). The 
diagnosis of  stroke was based on the World Health Organization criteria. The diagnosis was made within 24 hours of  admission in 19 
patients (38%). Acute revascularisation therapy was not available. Forty-eight patients (96%) had their vital signs checked at baseline 
and <10% had their vital signs checked more than three times within the first 24 hours. Essential blood tests including random blood 
sugar (RBS), full blood count (FBC), urea/creatinine, and lipid profiles were performed in 72%, 68%, 48%, and 4%, respectively. An 
electrocardiogram was performed on 34 patients (68%). Blood pressure on admission was >140/90 mmHg in 34 patients (68%), 
including 4 with values >220/120 mmHg. Nine patients had an RBS >10 mmol/L and four received insulin. Prophylaxis for deep 
venous thrombosis was offered to 12 patients (24%). Aspiration pneumonia was reported in 16 patients (32%) and was the most 
common hospital complication. The mean duration of  hospitalisation was 10.4 days (95% CI: 5.6–15.2), and case fatality was 18%. 
The modified Rankin scale at discharge was ≤2 in 32% of  patients. Only four patients (8%) were transferred to a rehabilitation centre. 
At the time of  discharge, only 32% of  patients received education on stroke.
Conclusion
Acute stroke care is less than optimal in this setting. Simple interventions such as reducing the delay in making a stroke diagnosis, early 
swallow assessments, and closer monitoring of  vital signs could make a significant difference in stroke outcome. Furthermore, treating 
cardiovascular risk factors and setting up health education programmes to improve secondary prevention represent key priorities.
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address this knowledge gap by conducting an audit to collect 
data on stroke management and outcomes at QECH and 
identify key areas for improvement. Being the first audit 
conducted at QECH, the findings will form the basis of  
future studies to assess the impact of  the stroke unit on 
patient care and outcomes and decisions on future resource 
allocation.
Methods
Selection of patients and data collection
From 1 April to 30 June 2018, we prospectively enrolled 
all patients aged 18 years and above diagnosed with an 
acute stroke who presented at QECH in Blantyre within 
14 days of  onset of  symptoms. QECH is Malawi’s largest 
referral and teaching hospital which receives patients from 
surrounding district hospitals, health centres, and private 
healthcare facilities. The hospital has an official bed capacity 
of  1350 but usually the number of  patients admitted exceeds 
this capacity (personal communication from Mr Chisi, 
QECH hospital administrator). The diagnosis of  stroke was 
made on admission by the attending clinician. Patients were 
excluded if  they were subsequently diagnosed with a non-
vascular cause for their neurological deficit.
A pre-designed case report form was used to collect data on 
patients’ demographics, clinical presentation, cardiovascular 
risk factors, investigations performed and their results, 
inpatient care plan, in-hospital outcomes, and follow-up 
plans after discharge. Data were exclusively obtained through 
a review of  medical records, except when assessing the 
overall satisfaction with care before discharge. This was done 
to minimise the interactions between the auditors, patients 
and health personnel. The auditors were formally instructed 
to avoid interfering with management.
Data management and analysis
Data were entered in Research Electronic Data Capture 
software (REDCap consortium, Vanderbilt University, 
TN, USA), then cleaned and validated by two independent 
data officers. Data analysis was performed using STATA 
(version 13, StataCorp LLC, College Station, TX, USA). 
Participants’ demographic and clinical data were summarised 
as proportions or means with 95% confidence intervals 
for categorical or continuous variables, respectively. The 
American Heart Association/American Stroke Association 
(AHA/ASA) guidelines10 were used as the standard to 
interpret the data and assess the quality of  current stroke care 
in Malawi. Although written for high-income settings, these 
guidelines incorporate the latest evidence in clinical stroke 
care and provide clear, specific, and quantifiable criteria for 
the management of  acute stroke.
Ethical considerations
All patients or their guardians provided written informed 
consent to participate in the audit, which was approved by the 
University of  Malawi, College of  Medicine Research Ethics 
Committee (COMREC) (Approval number P.02/18/2361) 
and the senior management team of  QECH.
Results
Baseline characteristics of the participants
We enrolled 50 patients diagnosed with stroke, including 
23 women (46%) and 27 men (54%). Seventy-five per cent 
of  the patients were referred from health centres within 
Blantyre district while the remaining 25% were self-referrals 
from surrounding districts. The mean age of  our study 
participants was 63.1 (95% CI, 59.7–66.6). More than half  of  
the patients, 27 (54%), enrolled in this study had a primary 
school education (27; 54%). Fifteen participants (30%) 
had a salaried job while the others were either in informal 
employment (26; 52%) or not working at all (9; 18%).
Twenty-four patients (48%) reached the hospital within 24 
hours of  stroke onset. There was no age or sex difference 
between patients arriving at the hospital within 24 hours of  
stroke onset and those arriving 24 hours after stroke onset. 
In these subgroups, the mean age was 61.8 and 64.4 (P=0.44) 
while the proportion of  women was 43.4 and 56.5 (P=0.58), 
respectively. 
Table 1. Summary of the demographics and clinical characteristics 





Age in years  
Mean 63.1 (95% CI: 59.7–66.6)





Income status  
Fixed monthly income 15 (30%) 
Variable daily income 11 (22%)
Occasional income 15 (30%)
No income 9 (18%)
Residence  
Within Blantyre 37 (75 %) 
Outside Blantyre 13 (25 %)
Stroke risk factors
Hypertension 25 (50%)
Diabetes mellitus 10 (20%)
Smoking 13 (26%)
Alcohol consumption 14 (28%)
History of heart disease 0 (0%)
Physical inactivity 40 (80%)
Personal history of stroke 11 (22%)
Family history of stroke 15 (30%)
Common presenting symptomsa
Motor deficit (upper or lower 
limbs) 
44 (88%)
Altered consciousness 29 (58%)
Altered speech 15 (30%)
Altered sensation 0 
Facial asymmetry 16 (32%)
Altered balance 2 (4%)
aThe presenting symptoms are listed as they were recorded in the 
patients’ files; some patients could have more than one presenting 
symptom
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Table 2. Quantification of the gap between selected ASA/AHA recommendations current practice at QECH
AHA/ASA recommendation Current practice at QECH Comments
Stroke severity should be ascertained, 
preferably using the NIHSS scale.
Not done
Patients with acute stroke should receive 
brain imaging evaluation on arrival to 
hospital (NCCT scan ideal).
Not available At the time of this audit, QECH did not 
have a functioning CT scanner. Only three 
patients had an MRI on day 7, 8 and 9 post-
admission. 
Vital signs check done on admission and at 
least every 4 hours during the first 48 hours.
Admission check: BP 
(98%), temperature (82%), 
pulse rate (98%), oxygen 
saturation (62%)
A check was not done every 4 hours, even 
for patients managed in HDU. 
IV thrombolysis – AIS, less than 4.5 hours. Not available No resources to allow for these acute 
interventions. The time window could allow 
mechanical thrombectomy in up to 48% of 
patients (who reached the hospital within 24 
hours of symptoms onset).Mechanical thrombectomy – AIS, up to 24 hours.
Not available
Blood glucose should be checked in all 
patients.
36 (72%) checked
Blood pressure control 
BP >220/120 mmHg – urgent lowering by 
15%
BP <220/120 mmHg – not to be treated in 
first 48–72 hours
4 patients with BP 
>220/130
3 had urgent lowering
12/18 (67%) received 
drugs
There were variations in the management of 
raised BP among clinicians. Some allowed 
a raised BP in the first 48 hours while others 
treated it. 
Aspirin to be administered in AIS patients 
within 24–48 hours after onset.
38 (76%) received Among those who received aspirin, all 
had it orally, regardless of the level of 
consciousness. Standard dose: 75 mg
Aspirin is only available in oral form in the 
hospital.
Urgent anticoagulation not recommended. Adhered to No patient received anticoagulation in the 
first 72 hours.
Patients to be managed in specialised 
stroke units.
Not available
Airway support and ventilatory assistance 
recommended for patients who have 
decreased consciousness or bulbar 
dysfunction (maintain oxygen saturation 
>94%).
9/29 (31%) received 
oxygen
Patients could only receive supplemental 
oxygen when admitted to the HDU. There is 
limited bed space in the HDU for all medical 
patients.
Starting or restarting antihypertensive 
therapy during hospitalisation in patients 
with blood pressure >140/90 mmHg who 
are neurologically stable is safe and is 
reasonable.
98% of hypertensive 
patients received 
The choice of antihypertensive drug to 
prescribe is determined by what is in stock 
in the pharmacy. 
Sources of hyperthermia (temperature 
>38°C) should be identified and treated. 
Antipyretic medications should be 
administered to lower temperature in 
hyperthermic patients with stroke.
5/5 (100%) with fever 
treated
Paracetamol was prescribed as an 
antipyretic. FBC, chest X-ray, and rapid 
malaria tests were done to investigate fever.
Aim to maintain normal blood sugar. Treat 
hyperglycaemia and hypoglycaemia.
4/11 (36%) received insulin 
to treat hyperglycaemia
Uncontrolled hyperglycaemia was a 
common complication observed. 
Dysphagia screening before the patient 
begins eating, drinking, or receiving oral 
medications.
Not done Level of consciousness seemed to have 
guided clinicians and nurses to insert NGT.
In immobile patients with stroke and without 
contraindications, intermittent pneumatic 
compression is recommended to reduce the 
risk of DVT.
Not available DVT prophylaxis offered to 12 patients. 
The majority (n = 9) received LMWH (2 had 
standard heparin and 1 stockings). In all 12 
patients, prophylaxis was started 48 hours 
after admission.
Routine screening and treatment of post-
stroke depression.
Not done
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Physiotherapy to be started in-hospital 
ideally after 24 hours.
60% received 
physiotherapy
2 patients started within 
48 hours
Physiotherapy students provided many 
services to patients. There was a sharp 
decline in physiotherapy sessions soon after 
the students went on holiday. 
Cardiac monitoring to screen for atrial 
fibrillation/serious cardiac arrhythmias. To be 
performed for at least the first 24 hours.
34 (68%) had an ECG 
7/34 had it on the first day 
of admission 
ECG is usually performed by one officer 
within the medical department who has 
other duties as well. No prolonged cardiac 
monitoring is done.
Diabetes screening (HbA1c usage 
recommended).
Not done QECH rely on RBS for diabetes screening.
High-dose statin therapy should be initiated 
or continued as first-line therapy in women 
and men ≤75 years of age who have clinical 
ASCVDa unless contraindicated.
4% were prescribed statins QECH pharmacy does not stock statins. 
Patients had to purchase these drugs from 
private pharmacies.
In-hospital counselling for smoking 
cessation. 
Not done Not formally done. Some clinicians would 
discuss it with patients while doing rounds.
Patient education about stroke is 
recommended. 
32% had stroke education Medical students/student nurses were 
mostly involved with patients that received 
education. Not a structured education.
Table 2 Cont....
The main cardiovascular risk factors identified were physical 
inactivity (80%) and hypertension (50%). Other reported risk 
factors were diabetes mellitus (20%), current smoking (26%), 
ongoing alcohol consumption (28%), previous history of  
stroke (22%) and family history of  stroke (30%). The most 
common presenting symptoms were limb weakness (88%), 
altered level of  consciousness (58%), facial asymmetry (32%) 
and aphasia (30%). Table 1 summarises the demographic and 
clinical characteristics of  the study participants.
Diagnosis and destination
None of  the patients were assessed for stroke severity using 
the National Institutes of  Health Stroke Scale (NIHSS) 
(http://www.nihstrokescale.org/). In all patients, the 
diagnosis of  stroke was based on the clinical presentation. 
Only three patients (6%) subsequently had MRI scans of  
the brain on day 7, 8 and 9 post-admission, respectively. The 
diagnosis of  stroke was made within 24 hours in 19 patients 
(38%), between 24 and 72 hours in 25 patients (50%), and over 
72 hours in 6 patients (12%). Forty-one patients (82%) were 
admitted to the general medical wards, while the remaining 
nine (18%) were admitted to the High Dependency Unit 
(HDU). Of  the 29 patients (58%) who had a reduced level 
of  consciousness, only nine were admitted to the HDU and 
received supplemental oxygen therapy. Patients in the general 
medical wards did not receive oxygen. Table 2 summarises 
the differences between the management of  patients with 
stroke at QECH and the AHA/ASA guidelines.
Monitoring and investigations
On admission, blood pressure was checked in 48 patients 
(96%), temperature in 41 patients (82%), and oxygen 
saturation in 31 patients (62%). Only five patients (10%) 
had their vital signs checked more than three times within 
the first 24 hours. None of  the participants had dysphagia 
screening.
The random blood sugar (RBS), full blood count (FBC), 
urea/creatinine tests, and lipid profiles were performed in 36 
(72%), 34 (68%), 24 (48%) and two (4%) patients, respectively. 
Two patients had liver function tests. Electrolytes and lipid 
profile tests were performed in a private laboratory since 
these tests are not offered by the QECH core laboratory. 
Syphilis test (Venereal Disease Research Laboratory) and 
coagulation tests were not performed on any patient though 
the former is available at QECH. An electrocardiogram 
(ECG) was performed on 34 patients (68%) but only seven 
patients had it within 24 hours of  admission. Fifteen patients 
(30%) had a cardiac ultrasound scan during their hospital 
stay, and none had an ultrasound examination of  the cervical 
and intracranial arteries. 
Treatment
Blood pressure on admission was >140/90 mmHg in 68% 
of  patients, of  whom four had values >220/120 mmHg. 
A total of  17 patients received antihypertensive treatment 
within 48 hours of  admission, including three patients with 
blood pressure >220/120 mmHg. Nine patients had RBS 
>10 mmol/L and four of  them received insulin to correct 
hyperglycaemia. Low dose aspirin was administered orally to 
38 patients (76%), regardless of  their level of  consciousness. 
An intervention to prevent deep venous thrombosis (DVT) 
was administered in 12 patients (24%), including low 
molecular weight heparin (n = 9), unfractionated heparin (n 
= 2), or compression stockings (n = 1). The DVT prophylaxis 
was initiated after 48 hours in all 12 cases. Throughout their 
hospital stay, 30 patients (60%) received physiotherapy with 
only two starting treatment within 48 hours. The mean 
number of  physiotherapy sessions was 3.1 (95% CI: 2.3–
3.8) with only seven having four or more sessions. Acute 
revascularisation therapy (intravenous thrombolysis or 
endovascular thrombectomy), speech and language therapy, 
AIS, acute ischaemic stroke; AHA, American Heart Association; ASA, American Stroke Association; ASCVD, atherosclerotic cardiovascular 
disease; BP, blood pressure; DVT, deep venous thrombosis; ECG, electrocardiogram; FBC, full blood count; HbA1c, glycated haemoglobin; 
HDU, high dependency unit; LMWH, low molecular weight heparin; NCCT, non-contrast CT; NGT, nasogastric tubes; NIHSS, National Institutes 
of Health Stroke Scale; QECH, Queen Elizabeth Central Hospital; RBS, random blood sugar.
aClinical ASCVD: acute coronary syndromes, history of myocardial infarction, stable or unstable angina, coronary or other arterial 
revascularisation, stroke, transient ischaemic attack (TIA), or peripheral arterial disease presumed to be of atherosclerotic origin.
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Table 3. Overview of the essential stroke service available at QECH 
according to the World Stroke Organisation roadmap
Component of acute stroke care/ service 
required
Service availability
Access to basic diagnostic services
Laboratory blood test 1
Computed tomography (CT) 0
Electrocardiogram (12 lead) 1 
CTA 0
Doppler ultrasound 0
Access to stroke trained health professionals 





Access to stroke specialists through 
telestroke modalities and teleradiology
*
Access to acute inpatient stroke care, where admitted patients are 
treated 
Stroke unit 0
Scattered throughout hospital 1
Protocols to guide acute stroke care based on best practice 
guidelines
Medical and nursing assessments 0
Swallow screen 0
Bladder and bowel continence 0
Severity scoring (NIHSS) 0
Skin integrity, DVT risk, mobility 0
Interdisciplinary meetings weekly 0




Patient and family education, skills training, 
and involvement in care planning
1
Access to stroke prevention therapies 
such as aspirin, lifestyle change 
recommendations, blood pressure 
management
1
Stroke training programmes for all levels of 
healthcare providers
0
1, service available; 0, service unavailable;*, sporadic availability 
(visiting specialists who usually stay for short periods of time).
NB: This is a report of what is available at QECH, and not the extent 
to which the service is fully utilised in stroke patient care.
and occupational therapy were not offered to any of  the 
patients as these treatments were not available.
Outcome
The most common in-hospital complications were aspiration 
pneumonia (32%) and thromboembolic events (24%). 
Other recorded complications were uncontrolled diabetes 
mellitus (10%), urinary tract infection (6%), malaria (6%), 
and pressure sores (4%). In-hospital death occurred in six 
patients (12%) and three additional deaths occurred within 48 
hours after discharge. The mean duration of  hospitalisation 
was 10.4 days (95% CI: 5.6–15.2). The modified Rankin 
scale11, a measure of  disability due to stroke, at discharge was 
2 or lower in 32% of  patients, 3–5 in 56%, and 6 in 12%. 
Patients were mostly discharged to their homes and only 
four patients (8%) were transferred to a rehabilitation centre. 
Half  of  the patients were given a follow-up appointment 
date on discharge. The time-to-first appointment ranged 
from 14 to 60 days. At the time of  discharge, 35 patients 
(70%) were aware of  their diagnosis and only 16 patients 
(32%) had received education on stroke. On a scale ranging 
from 0 to 10, 64% of  patients indicated a satisfaction score 
of  6 or higher with respect to the overall care received during 
their hospital stay. 
Discussion
We conducted the audit to understand the management of  
patients with stroke at QECH and to inform the design and 
implementation of  future initiatives to improve the care of  
patients with stroke in Malawi. To our knowledge, this is the 
first audit done to document stroke management practices at 
QECH. Our findings show that there are huge gaps between 
international evidence-based stroke management guidelines 
and current practices. Specifically, there is no consistent 
and structured implementation of  any guidelines in the 
management of  patients with stroke. While the absence of  
radiological imaging (e.g. CT scan), key laboratory services, 
and drugs are the main reasons for the poor uptake of  
evidence-based practice, the audit found underutilisation of  
available services at QECH.
Despite the poor referral system for patients in Malawi12, 
nearly half  of  the participants arrived at the hospital 
within the first 24 hours after the onset of  symptoms. 
This highlights an opportunity to intervene early and 
thus reduce hospital death and disability. The absence of  
revascularisation therapies does not negate the opportunity 
to make a difference with a more systematic approach. An 
addressable area is the delay in making a stroke diagnosis 
and initiating in-hospital management. In the absence of  a 
CT scan, a stroke diagnosis is made clinically, most often 
using the World Health Organization definition13,14. An 
experienced stroke physician will make the correct diagnosis 
in 85% of  cases15, but the accuracy is likely to be lower in less 
experienced clinicians who are at the forefront of  managing 
patients with stroke when they present at QECH. However, 
with a focus on training, led by stroke experts within a stroke 
platform, there is an opportunity to improve the clinical 
acumen of  less experienced clinicians in recognising stroke. 
Although we did not look specifically at former hospital 
encounters, a previous stroke study at QECH suggests that 
at least 10% of  patients have stroke symptoms before their 
main stroke16. Therefore, training the accident and emergency 
staff  to recognise minor stroke symptoms may improve risk-
stratification and help reduce the number of  patients that 
may return and present with a more severe stroke.
Early clinical deterioration was found in more than half  
of  the patients enrolled. In most cases, the deterioration 
was attributed to medical complications, with aspiration 
pneumonia being the most prevalent. This is likely because 
patients do not undergo dysphagia screening and very few 
patients with reduced level of  consciousness are fed or 
receive drugs through nasogastric tubes. Formal and early 
evaluation of  swallow function and appropriate dietary 
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modifications in patients with stroke are crucial to prevent 
respiratory infections17,18. Early mobilisation and respiratory 
physiotherapy will also contribute to improve respiratory 
function and prevent pneumonia in an acute stroke setting19.
In recent years, physiotherapy services have improved 
in Malawi. More than half  of  the patients in this audit 
received physiotherapy during their hospital stay, although 
the rehabilitation was initiated late with a few sessions 
conducted during hospitalisation. Referral to a rehabilitation 
centre is facilitated by a physiotherapist upon request by the 
attending physician. In this audit, only four patients (8%) 
were transferred to a rehabilitation centre at the end of  acute 
stroke care. Strengthening multidisciplinary collaboration 
will help to get physiotherapists involved in the care process 
early and will facilitate appropriate triaging to the only 
rehabilitation unit in Blantyre.
The three deaths that occurred less than 2 days after 
discharge may suggest that patients are discharged before 
they are fit to go home. The mean length of  stay was 10.4 
days and is comparable to the average of  8.5 days found in 
a cross-sectional study conducted in four tertiary hospitals 
in Malawi20, but lower than the average 18.5 days reported 
by Heikinheimo et al. at the same hospital in 20126. Earlier 
patient discharge is explained by the contrast between the 
increasing demand for hospitalisation and the limited number 
of  medical beds at the hospital. This may also contribute to 
the overall mortality, which was 18% in this audit (including 
the three patients who died within 48 hours post-discharge). 
This is higher than the mortality rates observed in middle- to 
high-income countries21,22.
This audit revealed inconsistencies in many aspects of  the 
management of  patients with stroke, which is likely due to 
the absence of  clear stroke management guidelines endorsed 
by local authorities. For example, some patients received 
antihypertensive medication within the first 48 hours of  
stroke onset despite having blood pressure below 220/120 
mmHg. It is not recommended to treat blood pressure 
below this threshold in the hyperacute phase, especially for 
ischaemic stroke10. In addition, only four patients received 
insulin out of  the nine admitted with a blood glucose >10 
mmol/L whereas current AHA guidelines recommend that 
blood glucose levels should be maintained between 7.8 
and 10 mmol/L10. Indeed, several studies have reported 
an association between hyperglycaemia and poor stroke 
outcomes23,24.
The last three decades have seen a major change and 
improvement in the management of  stroke globally. 
Mechanical thrombectomy, intravenous thrombolysis, 
carotid endarterectomy, strict control of  stroke risk factors, 
and managing patients in a stroke unit have proven effective 
in improving outcomes25–27. Given the current infrastructure 
and available resources8, QECH may not be able to implement 
these advanced interventions soon. However, setting up 
a stroke unit is feasible. Reducing the delay in making a 
diagnosis of  stroke or starting rehabilitation, improving the 
monitoring of  patients’ vital signs, controlling cardiovascular 
risk factors, and setting up health education programmes 
to improve secondary stroke prevention represent priority 
needs that the stroke unit should address. The World Stroke 
Organisation (WSO) devised a road map for delivering 
acute stroke care that gives realistic expectations of  what 
different settings should have in terms of  both resources 
and services. From our experience in conducting this audit, 
and with data reported in a case report that reflected on 
the challenges of  stroke management in resource-limited 
settings8, QECH falls in the ‘minimum healthcare services’ 
category of  the WSO roadmap. Table 3 summarises the 
available resources and services at QECH. With such 
structural limitations, it would be expected that stroke care 
service provision would be suboptimal. Our audit found that 
the challenge of  limited resources in this setting is further 
exacerbated by underutilisation of  services that are already 
available. The laboratory has the capacity to perform FBC 
and kidney function tests, but these tests were not requested 
in all patients. These basic tests can have important clinical 
implications for stroke care. For instance, a low platelet count 
may raise suspicion of  intracranial bleeding and would deter 
the administration of  aspirin, whereas polycythaemia and 
leucocytosis may suggest a diagnosis of  ischaemic stroke28,29.
The strengths of  this audit are the prospective consecutive 
recruitment of  patients and the rigorous collection and 
management of  data. Its limitations include the small sample 
size due to time and budgetary constraints. Moreover, as 
the data collection was based mainly on chart reviews, we 
assumed that any intervention not documented was not 
performed. This assumption may not be true in some 
cases. Lastly, the audit lacked a follow-up component. Data 
on stroke mortality and functional outcome at 3 months 
and compliance with the follow-up calendar would have 
been useful to inform the planning of  long-term care after 
discharge.
Conclusion
This audit has unveiled a significant gap between current 
stroke management practices at QECH and international 
evidence-based guidelines. Reducing the delay in making 
a stroke diagnosis, performing early dysphagia screening, 
improving the monitoring of  patients’ vital signs and the 
control of  their cardiovascular risk factors, and setting 
up health education programmes to improve secondary 
prevention represent urgent and achievable goals. It is 
also important to optimise the use of  available resources, 
strengthen the multidisciplinary approach in providing 
care to patients with stroke through regular meetings and 
continuing medical education programmes, and develop 
local care protocols with clearly defined evidence-based 
clinical pathways that are appropriate to this setting and the 
resources available.
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